Marksans Pharma strengthens European presence with €7.5 million QliniQ acquisition - CNBC TV18
Marksans Pharma→Teva Pharmaceuticals Ireland and Teva Pharmaceuticals Canada
Jun 1, 2026
Impact Advisors has acquired Canopii Collaborative, a healthcare IT business in the United States. Canopii Collaborative supports healthcare organizations with collaborative technology and workflow enablement that can be integrated into existing healthcare IT environments. Impact Advisors acquisitions in healthcare IT are positioned to expand capabilities for teams focused on patient-facing and operational coordination, including add on acquisition opportunities. The Canopii Collaborative acquisition is an announced add on acquisition as part of Impact Advisors acquisitions strategy, with deal size undisclosed and terms not publicly specified.
Marksans Pharma→Teva Pharmaceuticals Ireland and Teva Pharmaceuticals Canada
Jun 1, 2026
Marksans Pharma→QliniQ
Jun 1, 2026
Frazier Healthcare Partners→Altruix
May 31, 2026
Signos
May 31, 2026
Sterling Bay→Pacific Center
May 29, 2026